 SAN DIEGO--BUSINESS WIRE--Biocept, Inc. Nasdaq: BIOC, a leading provider of molecular diagnostic assays, products and services, will host a webinar featuring leading neuro-oncologists to discuss the use of the Companys proprietary cerebrospinal fluid CSF assay for diagnosing and managing tumors that have metastasized to the central nervous system CNS, including the brain or spinal column. Biocepts CSF assay provides enhanced sensitivity compared with CSF cytology, the current standard 